Spectral Medical Provides Tigris Trial Update
April 10, 2024 07:00 ET
|
Spectral Medical Inc.
101 patients enrolled TORONTO, April 10, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for...
Spectral Medical Chair to Retire From the Board of Directors
April 02, 2024 08:00 ET
|
Spectral Medical Inc.
TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic...
Spectral Medical Announces Fourth Quarter and Fiscal 2023 Results and Provides Corporate Update
March 28, 2024 16:00 ET
|
Spectral Medical Inc.
TORONTO, March 28, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic...
Spectral Medical Provides February Tigris Trial Update
February 28, 2024 07:30 ET
|
Spectral Medical Inc.
93 patients enrolledFebruary represents a second record breaking consecutive month for patient enrollment TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the...
Spectral Medical Announces Amendment and Extension of Exclusive Supply and Distribution Agreement With Baxter Healthcare Corporation
February 21, 2024 16:00 ET
|
Spectral Medical Inc.
TORONTO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Announces Major Milestone by Reaching Its Interim Enrollment Target of 90 Patients
February 15, 2024 07:41 ET
|
Spectral Medical Inc.
TORONTO, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Provides Early February Tigris Trial Update
February 05, 2024 07:30 ET
|
Spectral Medical Inc.
88 patients enrolled January being the highest enrollment month since the launch of Tigris TORONTO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the...
Spectral Medical Provides January Tigris Trial Update
January 30, 2024 07:30 ET
|
Spectral Medical Inc.
TORONTO, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Enrolls Patient 82 in Its Phase 3 FDA Tigris Septic Shock Trial
January 10, 2024 07:00 ET
|
Spectral Medical Inc.
New patient enrollment sites accelerating screening activityScreening activity exceeding 100 patients per weekApproaching interim enrollment target of 90 patients TORONTO, Jan. 10, 2024 (GLOBE...
Spectral Medical Provides Tigris Trial Update
December 14, 2023 08:00 ET
|
Spectral Medical Inc.
81 patients enrolled TORONTO, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for...